Brain Edema
📧 Sign up to get email alerts when something new happens for Brain Edema.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-10-01Clinical Trial Update: Effect of Volatile- Based Versus Total Intravenous Anesthesia on Brain Homeostasis and Neurocognitive Outcome [Phase 4]
A Phase 4 clinical trial comparing volatile-based anesthesia with total intravenous anesthesia to assess brain homeostasis and neurocognitiv…
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Setting Families on a Positive Path to Recovery After Pediatric TBI: Road-to-Recovery [NA]
A pediatric traumatic brain injury trial called Road-to-Recovery is currently recruiting, sponsored by Cincinnati Children's Hospital Medica…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Swiss Prospective Autologous Bone Flap Resorption Study
This clinical trial update notes termination of a prospective study from the University of Zurich evaluating autologous bone flap resorption…
-
CLINICAL_TRIALS research · 2024-05-10Clinical Trial Update: Haemodynamical Optimization During Brain Surgery [NA]
A clinical trial sponsored by University Hospital Hradec Kralove is recruiting to evaluate haemodynamical optimization during brain surgery …
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Effect of Mannitol 20% Versus Hypertonic Saline 7.5% in Brain Metabolism and Oxygenation [Phase 4]
A Phase 4 trial comparing Mannitol 20% to Hypertonic Saline 7.5% in brain metabolism and oxygenation for brain edema/metabolic disturbances …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
EMA withdrawal · 2021-03-19EMA Application withdrawn: Dexamethasone Taw (Dexamethasone (sodium phosphate)) — Taw Pharma (Ireland) Ltd
EMA withdrew the application for Dexamethasone Taw (dexamethasone sodium phosphate) by Taw Pharma (Ireland) Ltd.
-
CLINICAL_TRIALS trial_result · 2019-08-19Clinical Trial Update: Goal-Directed Intraoperative Fluid Management Using FloTrac© Monitoring in High-Risk Neurosurgical Patients [NA]
A completed clinical trial evaluating goal-directed intraoperative fluid management using FloTrac monitoring in high-risk neurosurgical pati…
-
CLINICAL_TRIALS trial_result · 2015-11-02Clinical Trial Update: A Comparison Between Two Techniques for Performing Decompressive Craniectomy [NA]
This clinical trial compared two techniques for performing decompressive craniectomy; the study on patients with brain edema and traumatic b…
-
CLINICAL_TRIALS trial_result · 2014-10-28Clinical Trial Update: Teen Online Problem Solving (TOPS) - An Online Intervention Following TBI [NA]
Completed clinical trial update for NCT00409058 evaluating the Teen Online Problem Solving (TOPS) online intervention after traumatic brain …
-
CLINICAL_TRIALS trial_result · 2014-08-13Clinical Trial Update: XERECEPT® (hCRF) for Patients Requiring Dexamethasone to Treat Edema Associated With Brain Tumors [Phase 3]
Phase 3 results update for XERECEPT (human corticotropin-releasing factor) in patients requiring dexamethasone to treat edema associated wit…
-
CLINICAL_TRIALS trial_result · 2014-07-30Clinical Trial Update: Correlation of Measured and Calculated Serum Osmolality During Hyperosmolar Drugs Infusion in Patients After Craniotomy [Phase 4]
Phase 4 clinical trial update assessing the correlation between measured and calculated serum osmolality during infusion of hyperosmolar dru…
-
CLINICAL_TRIALS trial_result · 2013-07-30Clinical Trial Update: Tolerability Study of Xerecept® in Pediatric Patients [Phase 1, Phase 2]
A Phase 1/2 tolerability study of Xerecept in pediatric patients with brain edema or brain tumors was terminated.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: An Open-Labeled, Extended-Use of XERECEPT (hCRF) for Patients in Studies NTI 0302, 0303, or Other Designated Studies [Phase 3]
Open-label, extended-use Phase 3 trial update of XERECEPT (hCRF) in patients from studies NTI 0302/0303 or other designated studies; the tri…
-
CLINICAL_TRIALS withdrawal · 2008-01-03Clinical Trial Update: XERECEPT® (hCRF) for Primary Glioma Patients Requiring Dexamethasone to Treat Peritumoral Brain Edema [Phase 3]
Phase 3 trial of XERECEPT (human corticotropin-releasing factor) in primary glioma patients requiring dexamethasone to treat peritumoral bra…